Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Survey on current practice in thrombophilia testing: from phenotype to genotype. Communication from the SSC of the ISTH.

Journal of thrombosis and haemostasis : JTH·2025
Same author

Diagnosing thrombophilia: the case for genetic or functional testing?

Expert review of molecular diagnostics·2025
Same author

Review of laboratory methods used for analysis of von Willebrand factor and for diagnosis of related diseases.

Expert review of hematology·2025
Same author

Von Willebrand factor is a multifaceted player in hemostasis requiring a diverse array of analytical and diagnostic approaches.

Expert review of hematology·2025
Same author

Development of a rapid and fully automated factor VIII inhibitor assay, insensitive to emicizumab, and a lowest level of quantification of 0.2 BU/mL.

Journal of thrombosis and haemostasis : JTH·2024
Same author

Thrombophilia Screening: Not So Straightforward.

Seminars in thrombosis and hemostasis·2024
Same journal

Nanotechnology-Stem Cell Strategies in 3D Glioblastoma Organoid: Targeting Glioma Stem Cells Within a Complex Tumor Microenvironment.

Methods in molecular biology (Clifton, N.J.)·2026
Same journal

Mapping the 3D Chromosome Organization of a Biosynthetic Gene Cluster by Capture Hi-C (CHi-C).

Methods in molecular biology (Clifton, N.J.)·2026
Same journal

Mapping the 3D Chromosome Organization of Streptomyces by Hi-C.

Methods in molecular biology (Clifton, N.J.)·2026
Same journal

CUT&Tag Epigenomic Profiling of Biosynthetic Gene Clusters in Arabidopsis thaliana.

Methods in molecular biology (Clifton, N.J.)·2026
Same journal

Rhizobium rhizogenes-Mediated Hairy Root Transformation Protocol for Lotus japonicus and Other Legumes.

Methods in molecular biology (Clifton, N.J.)·2026
Same journal

Characterization of Bioactive Saponins from Sea Cucumbers.

Methods in molecular biology (Clifton, N.J.)·2026
See all related articles

Related Experiment Video

Updated: Jul 29, 2025

Revised and Neuroimaging-Compatible Versions of the Dual Task Screen
07:52

Revised and Neuroimaging-Compatible Versions of the Dual Task Screen

Published on: October 5, 2020

3.6K

ADAMTS13 Activity: Screening Test Protocol.

Gary W Moore1,2,3, Margaret Griffiths4, Nikolaus B Binder4

  • 1Research and Development, Technoclone Herstellung von Diagnostika und Arzneimitteln GmbH, Vienna, Austria. gary.moore@addenbrookes.nhs.uk.

Methods in Molecular Biology (Clifton, N.J.)
|May 19, 2023
PubMed
Summary
This summary is machine-generated.

Accurate ADAMTS13 activity measurement is crucial for diagnosing thrombotic microangiopathies (TMA). The Technoscreen ADAMTS13 Activity assay offers a rapid, semiquantitative screening method for non-specialized settings.

Keywords:
ADAMTS13Flow-through assayRapid assayScreening testThrombotic microangiopathyThrombotic thrombocytopenic purpura

More Related Videos

Using Brain Activation nir-HEG/Q-EEG and Execution Measures CPTs in a ADHD Assessment Protocol
13:09

Using Brain Activation nir-HEG/Q-EEG and Execution Measures CPTs in a ADHD Assessment Protocol

Published on: April 1, 2018

10.4K
Traditional Trail Making Test Modified into Brand-new Assessment Tools: Digital and Walking Trail Making Test
08:07

Traditional Trail Making Test Modified into Brand-new Assessment Tools: Digital and Walking Trail Making Test

Published on: November 23, 2019

11.1K

Related Experiment Videos

Last Updated: Jul 29, 2025

Revised and Neuroimaging-Compatible Versions of the Dual Task Screen
07:52

Revised and Neuroimaging-Compatible Versions of the Dual Task Screen

Published on: October 5, 2020

3.6K
Using Brain Activation nir-HEG/Q-EEG and Execution Measures CPTs in a ADHD Assessment Protocol
13:09

Using Brain Activation nir-HEG/Q-EEG and Execution Measures CPTs in a ADHD Assessment Protocol

Published on: April 1, 2018

10.4K
Traditional Trail Making Test Modified into Brand-new Assessment Tools: Digital and Walking Trail Making Test
08:07

Traditional Trail Making Test Modified into Brand-new Assessment Tools: Digital and Walking Trail Making Test

Published on: November 23, 2019

11.1K

Area of Science:

  • Hematology
  • Clinical Chemistry
  • Diagnostic Assays

Background:

  • Accurate measurement of ADAMTS13 activity is essential for diagnosing and managing thrombotic microangiopathies (TMA).
  • Distinguishing thrombotic thrombocytopenic purpura (TTP) from other TMAs is critical for appropriate treatment.
  • Current quantitative ADAMTS13 assays often require specialized equipment and personnel, limiting accessibility.

Purpose of the Study:

  • To evaluate the Technoscreen ADAMTS13 Activity assay as a rapid, semiquantitative screening tool.
  • To assess the suitability of this assay for use in non-specialized laboratories and point-of-care settings.

Main Methods:

  • The Technoscreen ADAMTS13 Activity assay utilizes flow-through technology and an ELISA principle.
  • It is a simple-to-perform screening test that does not require specialized equipment or personnel.
  • Results are determined by comparing a colored endpoint to a reference color chart indicating activity levels of 0, 0.1, 0.4, or 0.8 IU/mL.

Main Results:

  • The Technoscreen ADAMTS13 Activity assay provides semiquantitative results rapidly.
  • Reduced ADAMTS13 activity levels detected by this screening test require confirmation with a quantitative assay.
  • The assay is designed for ease of use in various settings, including remote and point-of-care locations.

Conclusions:

  • The Technoscreen ADAMTS13 Activity assay is a valuable, rapid screening tool for assessing ADAMTS13 activity.
  • Its simplicity and minimal equipment requirements make it suitable for broader clinical application, including non-specialized laboratories.
  • This assay can aid in the initial diagnosis and management of TMAs, particularly in resource-limited settings.